The cytokine release syndrome has been proposed as the driver of inflammation in
coronavirus disease 2019 (COVID-19). However, studies on longitudinal cytokine profiles in …

Background High levels of serum interleukin-6 (IL-6) correlate with disease severity in
COVID-19. We hypothesized that tocilizumab (a recombinant humanized anti-IL-6 receptor) …

Background The severity and outcome of COVID-19 cases has been associated with the
percentage of circulating lymphocytes (LYM%), levels of C-reactive protein (CRP) …

Background COVID-19 is a multi-system disorder with high variability in clinical outcomes
among patients who are admitted to hospital. Although some cytokines such as interleukin …

Background The effectual immune response is crucial to defeat viral infections. However,
exuberant immune response with features of macrophage activation syndrome (MAS) lead …

Background Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic.
Because the severity of the disease is highly variable, predictive models to stratify patients …

Background Covid-19 is a disease with high morbidity and mortality among elderly residents
of long-term care facilities (LTCF). During an outbreak of SARS-CoV-2 infection in the LTCF …

Objective The hyperinflammatory response, caused by severe acute respiratory syndrome-2
(SARS-CoV-2), is the most common cause of death in patients with coronavirus disease …

Background and aims COVID 19 pneumonia commonly leads to ARDS. The occurrence of
ARDS in COVID 19 patients is thought to occur secondary to an exaggerated immunologic …

Background The inflammatory response plays a critical role in coronavirus disease 2019
(COVID-19), and inflammatory cytokine storm increases the severity of COVID-19. Objective …